Status:

ACTIVE_NOT_RECRUITING

Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Institutes of Health (NIH)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

Endometriosis

Endometrial Diseases

Eligibility:

FEMALE

18-45 years

Brief Summary

This study will test the hypothesis that the molecular changes present in ectopic endometriosis lesions correlate with progesterone-resistant disease (using the criteria defined in this study) and are...

Detailed Description

Tissues from 100 patients with endometriosis will be analyzed with droplet digital PCR (ddPCR) targeted sequencing and responders (n=50) will be compared to non-responders (n=50) after controlling con...

Eligibility Criteria

Inclusion

  • Signed informed consent.
  • Gender: female.
  • Age: 18-45 years at the time of signing consent.
  • Clinical or surgical diagnosis of endometriosis undergoing laparoscopy.
  • Controls may not have clinical or surgical diagnosis of endometriosis.
  • Regular menstrual cycles.
  • BMI between 18-40 kg/m2.
  • Sexually active or have had a previous vaginal exam that used a speculum.
  • English speaking

Exclusion

  • Use of any kind of steroidal therapy including oral contraceptives, Norplant, estrogen replacement/supplemental therapy, androgens (Danazol, Cyclomen, Danocrine, testosterone) or progesterone. She may not be taking or be on Celebrex.
  • Pregnant.
  • Presence of pelvic infection.
  • Mullerian anomalies with absence of a cervix.
  • History of cancer of the reproductive tract.
  • Presence of undiagnosed uterine bleeding.
  • Treatment with intrauterine device (IUD) or progestin-containing intrauterine device.

Key Trial Info

Start Date :

October 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2026

Estimated Enrollment :

135 Patients enrolled

Trial Details

Trial ID

NCT03756480

Start Date

October 1 2020

End Date

October 1 2026

Last Update

June 26 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Yale School of Medicine

New Haven, Connecticut, United States, 06510

2

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21218

3

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232